BENEFICIOS DE LA TROMBÓLISIS CON RT-PA EN PACIENTES CON EVENTO CEREBRO VASCULAR ISQUÉMICO, SEGÚN GRUPOS DE EDAD.

Abstract

STROKE is responsible for approximately 85% of cerebrovascular events worldwide. It causes significant neurological consequences and high public health costs. Thromboembolic therapy with rtPA has the property of reversing the neurological symptoms and is applied in the first 4 hours of the onset of symptoms. OBJECTIVE: Determine the benefits of thrombolysis with rtPA in patients with ischemic cerebrovascular events according to age groups METHODOLOGY: It is a quantitative study with an observational, cross-sectional and retrospective design. It collects information about the evolution, pathological history and NIHSS to then code it based on the designed variables and process them in the IBM SPSS 25 software. POPULATION: Of a universe of 406 cases reported as cerebrovascular events, 29 cases made up the population, meeting the inclusion criteria. RESULTS: There was a reduction between 3 to 5 points in the NIHSS post thrombolysis of each patient, including the oldest (71 to 90 years). 82.76% of the cases did not present adverse effects. 44.86% presented multiple comorbidities. CONCLUSIONS: The effectiveness of thrombolysis in reducing STROKE symptoms is evident in age groups of 81-90 years. Demonstrating that such treatment can reduce benefit to this age group and can be implemented safely.